Novavax signs licensing agreement with Pfizer for vaccine development
Go back to Novavax signs licensing agreement with Pfizer for vaccine development| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 7.74 +0.04 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.70 | 52 Week High | $9.23 | |||
| Open | $7.82 | 52 Week Low | $1.16 | |||
| Day High | $7.91 | P/E | N/A | |||
| Day Low | $7.53 | EPS | $-0.30 | |||
| Volume | 4,901,965 | |||||
